Q2 2020 Pieris Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Pieris Pharmaceuticals, Inc. Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Tom Bures, Vice President of Finance.
Good morning, everyone, and thank you for joining us for our second quarter 2020 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate update and outlook on our pipeline; Hitto Kaufmann, our Chief Scientific Officer; Ingmar Bruns, our SVP and Head of Clinical Development; and Shane Olwill, our SVP and Head of Translational Science, who will be available for Q&A. You can access the press release released this morning on the Investor Relations page of our website at www.pieris.com.
Before we begin, I'd like to caution that comments made during this conference call may contain
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |